Tech Company Financing Transactions
DecisionRx Funding Round
On 1/11/2024, DecisionRx raised $100 million in funding from The Carlyle Group and private investors.
Transaction Overview
Company Name
Announced On
1/11/2024
Transaction Type
Debt
Amount
$100,000,000
Round
Undisclosed
Investors
The Carlyle Group (Lead Investor) (Akhil Bansal)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
8 The Green A
Dover, DE 19901
USA
Dover, DE 19901
USA
Phone
Website
Email Address
Not Recorded
Overview
We are a healthcare technology company reducing the cost of care by helping physicians make better prescription recommendations that improve patient outcomes. DecisionRx helps mitigate medication failures including adverse events, ineffective drugs, and medication nonadherence.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jim Wallace
Chief Technical Officer
Laura Breedlove
President
Travis Morgan
VP - Operations
Hazem Elewa
Browse more venture capital transactions:
Prev: 1/11/2024: Rune Labs venture capital transaction
Next: 1/11/2024: Bitfinity Network venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on tech company VC transactions. VC investment data records on this site come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs